Premature Ovarian Insufficiency (POI), also called Premature Ovarian Failure (POF) or early menopause, occurs when the ovaries stop functioning normally before age 40. Symptoms include irregular or absent periods, hot flushes, and infertility. At Mother Hospitals, Boduppal, we offer POI management including fertility investigation, hormone replacement therapy (HRT), and donor egg IVF where needed. Led by Dr. E. Prashanthi Reddy (TGMC Reg: 50624). Call 97059 93366.
POI affects women under 40 when the ovaries stop functioning normally — causing missed periods, early menopause symptoms, and infertility. At Mother Hospitals, Boduppal, Dr. E. Prashanthi Reddy offers specialist POI assessment, HRT, and fertility pathways including donor egg IVF.
MBBS, DGO, PG Diploma in ART – Kiel University, Germany | 20+ Years Experience | TGMC Reg: 50624
Premature Ovarian Insufficiency — also known as Premature Ovarian Failure (POF) — is a condition in which the ovaries reduce or cease their normal hormone production and egg release before the age of 40. It is not the same as natural menopause, though the symptoms can overlap significantly. It affects approximately 1 in 100 women under 40 and 1 in 1,000 women under 30.
Natural menopause typically occurs between ages 45–55. POI occurs before age 40 — sometimes even in teenagers or women in their 20s. Unlike natural menopause which is permanent and gradual, POI can be intermittent: in some women, the ovaries have occasional periods of activity. This is why the preferred term is now "insufficiency" rather than "failure" — the condition is not always absolute.
Low AMH (Anti-Müllerian Hormone) indicates reduced ovarian reserve but does not on its own diagnose POI. POI requires both hormonal evidence (high FSH, low oestradiol) AND absent periods for at least 4 months in a woman under 40. A woman can have low AMH but still have regular periods — she does not have POI. However, POI is almost always accompanied by very low AMH. If you have been told your AMH is very low and your periods are absent or irregular, see our Low AMH treatment page.
POI symptoms arise because the ovaries are no longer producing normal levels of oestrogen and progesterone. Many women first notice absent or irregular periods. Other symptoms resemble those of menopause — but in a much younger woman, they should never be dismissed or left untreated.
Periods become erratic, infrequent (oligomenorrhoea) or stop altogether (amenorrhoea) for 4 months or more. This is usually the first sign women notice and seek evaluation for.
Sudden waves of heat, particularly at night, caused by falling oestrogen levels. These can severely disrupt sleep and quality of life in young women who are not expecting menopausal symptoms.
Low oestrogen causes vaginal tissues to become thinner and drier, leading to discomfort or pain during intercourse (dyspareunia) and increased urinary symptoms.
Anxiety, depression, poor concentration and memory difficulties are common — and are directly linked to oestrogen deficiency affecting brain function. These symptoms are often misdiagnosed as stress or anxiety disorder.
Falling oestrogen and testosterone levels reduce sex drive, compounded by vaginal dryness and emotional distress.
Oestrogen is essential for bone density maintenance. Without treatment, women with POI face significantly elevated risk of osteoporosis and fractures over time.
Reduced or absent ovulation means conception becomes very difficult without medical assistance. This is often the primary concern for younger women diagnosed with POI.
In many cases, no clear cause is found. When a cause is identified, it usually falls into one of four categories — genetic, autoimmune, iatrogenic (medically caused), or metabolic. Understanding the cause is important as it guides both treatment and genetic counselling for family members.
In approximately half of all POI cases, no specific cause can be identified even after thorough investigation. This is called idiopathic POI. The ovarian follicle pool is depleted faster than expected for no identifiable reason. Treatment focuses on symptom management and fertility options rather than addressing an underlying cause.
Turner syndrome (45,X) — a chromosomal condition where one X chromosome is missing or structurally abnormal, affecting ovarian development. Often diagnosed in childhood or adolescence.
FMR1 premutation (Fragile X carrier) — women who carry a premutation in the FMR1 gene have a significantly elevated risk (up to 20%) of developing POI. Genetic testing is recommended for all women with unexplained POI. This also has implications for sons who may develop Fragile X syndrome.
The immune system mistakenly attacks ovarian tissue. Autoimmune POI is often associated with other autoimmune conditions including Addison's disease (adrenal insufficiency), Hashimoto's thyroiditis, type 1 diabetes, and rheumatoid arthritis. All women with POI should be screened for adrenal antibodies, thyroid antibodies, and other autoimmune markers. Autoimmune adrenal disease can be life-threatening if missed.
Cancer treatment — particularly chemotherapy (especially alkylating agents such as cyclophosphamide) and pelvic radiotherapy — can damage ovarian follicles, sometimes permanently. Ovarian surgery (e.g., for endometrioma) can also reduce reserve significantly if performed without care. Women expecting cancer treatment should be urgently counselled about fertility preservation before treatment.
POI has specific diagnostic criteria. A single high FSH result is not sufficient — the European Society of Human Reproduction and Embryology (ESHRE) guidelines require two separate confirmatory tests before diagnosis is made.
FSH, LH, oestradiol (E2), prolactin, AMH, thyroid function (TSH, T4), testosterone
Karyotype (chromosomal analysis), FMR1 premutation screening (Fragile X carrier testing)
Adrenal antibodies (21-hydroxylase), thyroid antibodies (TPO, TgAb), antinuclear antibodies
DXA scan at diagnosis to assess bone mineral density — essential baseline since oestrogen deficiency risks osteoporosis even at a young age
Transvaginal ultrasound for antral follicle count (AFC) — though often very low, occasional follicles may be seen
A POI diagnosis does not mean the end of your dream of motherhood. While natural conception is difficult, modern reproductive medicine offers meaningful pathways to parenthood. The right option depends on your individual situation, ovarian activity, and personal preferences.
POI is not always permanent or absolute. In some women — particularly those with intermittent ovarian function — spontaneous ovulation and pregnancy can still occur. Studies show approximately 5–10% of women with POI conceive naturally over time. Regular monitoring is advisable for women wishing to attempt natural conception. If you have POI and do not wish to become pregnant, contraception is still needed during any periods of spontaneous ovarian activity.
For most women with POI who wish to conceive, donor egg IVF is the most effective route to pregnancy. In this treatment, eggs from a screened, anonymous donor are fertilised with your partner's sperm (or donor sperm) and the resulting embryo is transferred to your uterus. Because the uterus is not affected by POI — only the ovaries are — success rates with donor eggs are excellent, often 50–70% per cycle. At Mother Hospitals, we work with ICMR-regulated egg donation pathways under India's ART Act 2021.
Embryo adoption (or embryo donation) involves using embryos created by another couple — both donor eggs and donor sperm — and transferring them to your uterus. This is an option for couples where both egg and sperm donation would be required. Regulated under the ART Act 2021.
If your POI is caused (or at risk of being caused) by upcoming cancer treatment, fertility preservation before chemotherapy or radiotherapy is critical. Options include egg freezing (oocyte cryopreservation) and embryo freezing. These must be arranged urgently, often within 2–3 weeks of a cancer diagnosis, so please contact us immediately.
HRT is not optional for women with POI under 40 — it is a medically essential treatment. Unlike HRT in natural menopause (where benefits and risks must be carefully weighed), in POI the body is simply receiving hormones it should normally have at this age. The health risks of NOT taking HRT in POI are significant.
Oestrogen deficiency from age 20 or 30 means decades without protection for bones, heart, brain, and vaginal health. Women with untreated POI have markedly elevated risk of osteoporosis, cardiovascular disease, cognitive decline, and reduced life expectancy compared to women with normal ovarian function. HRT corrects this deficiency — it is replacing what should naturally be there, not adding extra hormones.
Oestrogen: Usually the main component. Available as oral tablets, transdermal patches, gel, or spray. Transdermal delivery (patches or gel) is often preferred as it avoids first-pass liver metabolism and may carry lower clot risk.
Progesterone / Progestogen: Added to protect the uterine lining if you have a uterus. Micronised progesterone (body-identical) is preferred for side-effect profile.
Testosterone: May be added for libido, energy, and cognitive function — particularly important in younger women with POI.
Oestrogen is the primary protector of bone mineral density. Women with POI who do not take HRT can lose significant bone density rapidly — comparable to the accelerated bone loss seen in the first years after natural menopause. DXA scanning at diagnosis and periodically thereafter is recommended. Calcium and vitamin D supplementation alongside HRT is standard practice at our clinic.
Natural oestrogen is cardioprotective in premenopausal women — it maintains healthy cholesterol levels, vascular flexibility, and blood pressure regulation. Women with POI who are oestrogen-deficient for many years have higher rates of cardiovascular disease. HRT commenced early (at the time of POI diagnosis) and continued at least until the age of natural menopause (~51 years) significantly reduces this excess risk. HRT does NOT increase breast cancer risk when used to treat POI under 40 — this is a common concern but the evidence is clear.
Receiving a diagnosis of premature ovarian insufficiency at 25, 30 or 35 can be devastating — particularly for women who had not yet started their families, or who had planned to. The grief is real and legitimate. It is a loss — of expected fertility, of a body that felt familiar, of a future that felt certain.
Many women with POI describe going through a profound grief process — disbelief, anger, sadness, and eventually, in time, acceptance and re-direction. These feelings are completely normal. They do not mean you are weak or not coping — they mean you are human and this matters to you deeply.
At Mother Hospitals, we make time for this conversation. Dr. E. Prashanthi Reddy and our team understand that a POI consultation is not just a medical appointment — it is often one of the most emotionally significant days in a woman's life. We offer unhurried consultations, space for questions, and referral to counselling support where needed.
If you have been diagnosed with POI and are struggling — please reach out. You do not have to navigate this alone.
Dr. E. Prashanthi Reddy completed her PG Diploma in ART from Kiel University, Germany — bringing international standards in reproductive medicine, hormonal care, and complex fertility management to Hyderabad.
Hormonal tests, genetic screening, autoimmune panel, DXA bone scanning, pelvic ultrasound, and fertility counselling — all coordinated at Mother Hospitals without referral delays.
We have an established, ICMR-regulated donor egg IVF programme for women with POI — offering the most effective route to pregnancy for those who need it.
We design HRT regimens tailored to your age, symptoms, bone density, cardiovascular risk, and fertility goals — not a one-size-fits-all prescription.
We understand the emotional weight of a POI diagnosis. Our consultations are unhurried and compassionate — giving you the time and space to ask questions and process your situation.
Easily accessible from Uppal, Nagole, Habsiguda, Ghatkesar, Keesara, Chengicherla, and surrounding areas. Ample parking. NRI teleconsultation available.
Yes — it is possible, though more difficult. Around 5–10% of women with POI conceive spontaneously during periods of intermittent ovarian activity. For most women with POI who wish to have children, donor egg IVF offers the most effective route to pregnancy, with success rates of 50–70% per transfer cycle. The uterus is not affected by POI, so it is fully capable of carrying a pregnancy. We will discuss all your options at consultation.
Not always. POI is not the same as absolute menopause — approximately 5–10% of women with POI have periods of spontaneous ovarian activity and even pregnancy. However, ovarian function generally continues to decline over time, and in most cases the condition is long-term. HRT is recommended regardless of whether ovarian function is intermittent, as oestrogen deficiency causes ongoing harm to bones, heart, and brain even when cycles occasionally return.
Natural menopause is defined as 12 consecutive months without periods after the age of 45–55, and is a normal life transition. POI occurs before age 40, is often not permanent, and carries significant health implications that natural menopause in older women does not — specifically, the accumulated years of oestrogen deficiency on bone, heart, and brain health. POI requires active management with HRT; natural menopause does not always.
HRT (oestrogen + progesterone) is not a fertility treatment — it does not stimulate ovulation or improve egg quality. It is given to protect your health (bones, heart, brain, vaginal health) against the effects of oestrogen deficiency. However, if spontaneous ovulation occasionally occurs in a woman on HRT, pregnancy is still possible. For actively trying to conceive, donor egg IVF is the most effective pathway for most women with POI.
There is no proven treatment that restores full ovarian function in POI. Occasional spontaneous recovery of ovarian activity is well documented — explaining the 5–10% spontaneous pregnancy rate — but this is not predictable and not something that can be induced reliably with current treatments. Research into ovarian rejuvenation techniques (PRP, stem cells) is ongoing but remains experimental and is not recommended as established therapy.
In about 50% of cases the cause is unknown (idiopathic). Known causes include chromosomal conditions (Turner syndrome), Fragile X premutation, autoimmune conditions (where the immune system attacks ovarian tissue), and iatrogenic causes — damage from chemotherapy, radiotherapy, or ovarian surgery. At Mother Hospitals we investigate all women with POI for these underlying causes, as some (like autoimmune adrenal disease) require treatment in their own right.
Yes — in almost all cases, HRT is strongly recommended for women with POI who are under 40, unless there is a specific medical contraindication. The risk of NOT taking HRT (osteoporosis, cardiovascular disease, cognitive decline) outweighs any risks associated with HRT in this age group. Unlike HRT prescribed for natural menopause in older women, HRT in POI is simply replacing hormones the body should naturally have at this age.
If your periods are absent or very irregular and you are under 40, a blood test for FSH, LH, oestradiol, and AMH is the first step. POI is diagnosed if FSH is elevated (>25 IU/L) on two separate occasions four weeks apart, in the context of absent or irregular periods lasting at least 4 months. At Mother Hospitals, we can arrange this testing and advise on the next steps. Call us on 97059 93366 or WhatsApp.
Dr. E. Prashanthi Reddy · TGMC Reg: 50624